A new Scientific Statement from the Heart Failure Society of America (HFSA) challenges longstanding ambiguity in the classification and treatment of heart failure with mildly reduced ejection fraction ...
Inconsistent adherence to the guidelines led to delayed heart failure treatment optimization and underutilization of key therapies. Published in the European Journal of Heart Failure, the survey ...
Panelists discuss how β-blockers remain foundational therapy for heart failure with reduced ejection fraction (using evidence-based agents like carvedilol, metoprolol succinate, or bisoprolol) with ...
The 2023 European Society of Cardiology (ESC) guidelines for acute and chronic heart failure (HF) include upgraded recommendations for intravenous (IV) iron supplementation, including Ferinject ® ...
Adults who have heart failure with a left ventricular ejection fraction of 40% or more face a high risk of hospitalization for heart failure and cardiovascular death. People who have heart failure ...
MINNEAPOLIS — Building on its initial success, researchers expanded a heart failure (HF) guideline-directed medical therapy clinic to treat more people with a wider range of left ventricular ejection ...
FLORENCE, ITALY – Unashamedly themed "Heart Failure: State of the Art" in the ancient home to the creations of Botticelli, Michelangelo, and Donatello, the European Cardiology Society (ESC) Heart ...
Heart failure presents a growing public health problem both in Estonia and across Europe. At the same time, its timely ...
Credit: Getty Images A 65-year-old woman presents to her primary care provider with a chief complaint of "feeling winded" for the last 3 weeks. A 65-year-old woman presents to her primary care ...
Most people who undergo chemotherapy do not develop heart failure. However, specific chemotherapy drugs may significantly increase your risk of heart failure and other cardiac problems. Chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results